本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

11.27
-0.3400-2.93%
盘后11.280.0100+0.09%19:07 EST
成交量:122.18万
成交额:1,387.28万
市值:12.62亿
市盈率:-7.01
高:11.50
开:11.48
低:11.24
收:11.61
52周最高:34.13
52周最低:10.87
股本:1.12亿
流通股本:9,414.79万
量比:0.70
换手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-1.6074
每股收益(LYR):-1.5638
净资产收益率:-50.60%
总资产收益率:-8.30%
市净率:3.70
市盈率(LYR):-7.21

数据加载中...

2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities